Evidence suggests that immunomodulatory factors like PD-1, PD-L2, and other cytokines are regularly expressed in brain metastases originating from breast and lung carcinoma, as well as melanoma [28,59,60]. The gene discussed is PDCD1LG2; the disease is melanoma.